diisopropanolnitrosamine
(MNIGYIKCFSPQRJ-UHFFFAOYSA-N)
Structure
- SMILES
- CC(CN(CC(O)C)N=O)O
- Molecular Formula:
- C6H14N2O3
- Molecular Weight:
- 162.187
- Log P:
- -0.2686
- Hydrogen Bond Acceptor:
- 5
- Hydrogen Bond Donor:
- 2
- TPSA:
- 73.13
- CAS Number(s):
- 53609-64-6
Synonym(s)
1.
diisopropanolnitrosamine
2.
1,1'-(nitrosoimino)bis(2-propanol)
3.
2,2'-BHP
4.
2,2'-dihydroxy-di-n-propylnitrosamine
5.
2,2'-dihydroxydipropylnitrosamine
6.
2-propanol, 1,1'-(nitrosoimino)bis-
7.
DHPN
8.
N-bis(2-hydroxypropyl)nitrosamine
9.
N-nitroso-bis(2-hydroxypropyl)amine
10.
N-nitrosobis(2-hydroxypropyl)amine
11.
N-nitrosodiisopropanolamine
12.
di(2-hydroxypropyl)nitrosamine
13.
nitroso-di-isopropanolamine
14.
nitrosobis(2-hydroxypropyl)amine
External Link(s)
| MeSH | C012457 |
| PubChem Compound | 40828 |
| ChEBI | 131518 |
| CHEMBL | CHEMBL350868 |
Adverse Drug Event(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Adenoma | 10945294 | CTD | |
| 2 | Alopecia | 29050248 | CTD | |
| 3 | Carcinoma | 10463772 10945294 11442016 | CTD | |
| 4 | Colonic Neoplasms | 1657429 | CTD | |
| 5 | Esophageal Neoplasms | 1399818 | CTD | |
| 6 | Hepatomegaly | 21864636 28245158 | CTD | |
| 7 | Hyperplasia | 21864636 | CTD | |
| 8 | Inflammation | 22387750 | CTD | |
| 9 | Liver Neoplasms, Experimental | CTD | ||
| 10 | Liver neoplasms | 3133336 | CTD | |
| 11 | Lung Neoplasms | CTD | ||
| 12 | Neoplasms, Experimental | 3133336 9065799 | CTD | |
| 13 | Nose Neoplasms | 10463772 10945294 11442016 | CTD | |
| 14 | Papilloma | 2591015 21864636 | CTD | |
| 15 | Precancerous Conditions | CTD | ||
| 16 | Stomach Neoplasms | 1399818 2591015 | CTD | |
| 17 | Thyroid cancer, follicular | 12824900 22387750 | CTD |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120262
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.